The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Myocardial Scar and Mortality in Severe Aortic Stenosis: Data From the BSCMR Valve Consortium
Open accessAbstract
Background: Aortic valve replacement (AVR) for aortic stenosis is timed primarily on the development of symptoms, but late surgery can result in irreversible myocardial dysfunction and additional risk. The aim of this study was to determine whether the presence of focal myocardial scar preoperatively was associated with long-term mortality. Methods: In a longitudinal observational outcome study, survival analysis was performed in patients with severe aortic stenosis listed for valve intervention at 6 UK cardiothoracic centers. Patients underwent preprocedural echocardiography (for valve severity assessment) and cardiovascular magnetic resonance for ventricular volumes, function and scar quantification between January 2003 and May 2015. Myocardial scar was categorized into 3 patterns (none, infarct, or noninfarct patterns) and quantified with the full width at half-maximum method as percentage of the left ventricle. All-cause mortality and cardiovascular mortality were tracked for a minimum of 2 years. Results: Six hundred seventy-four patients with severe aortic stenosis (age, 75±14 years; 63% male; aortic valve area, 0.38±0.14 cm 2 /m 2 ; mean gradient, 46±18 mm Hg; left ventricular ejection fraction, 61.0±16.7%) were included. Scar was present in 51% (18% infarct pattern, 33% noninfarct). Management was surgical AVR (n=399) or transcatheter AVR (n=275). During follow-up (median, 3.6 years), 145 patients (21.5%) died (52 after surgical AVR, 93 after transcatheter AVR). In multivariable analysis, the factors independently associated with all-cause mortality were age (hazard ratio [HR], 1.50; 95% CI, 1.11–2.04; P =0.009, scaled by epochs of 10 years), Society of Thoracic Surgeons score (HR, 1.12; 95% CI, 1.03–1.22; P =0.007), and scar presence (HR, 2.39; 95% CI, 1.40–4.05; P =0.001). Scar independently predicted all-cause (26.4% versus 12.9%; P <0.001) and cardiovascular (15.0% versus 4.8%; P <0.001) mortality, regardless of intervention (transcatheter AVR, P =0.002; surgical AVR, P =0.026 [all-cause mortality]). Every 1% increase in left ventricular myocardial scar burden was associated with 11% higher all-cause mortality hazard (HR, 1.11; 95% CI, 1.05–1.17; P <0.001) and 8% higher cardiovascular mortality hazard (HR, 1.08; 95% CI, 1.01–1.17; P <0.001). Conclusions: In patients with severe aortic stenosis, late gadolinium enhancement on cardiovascular magnetic resonance was independently associated with mortality; its presence was associated with a 2-fold higher late mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881
Schulz-Menger, J., Bluemke, D. A., Bremerich, J., Flamm, S. D., Fogel, M. A., Friedrich, M. G., Kim, R. J., von Knobelsdorff-Brenkenhoff, F., Kramer, C. M., Pennell, D. J., et al. (2013) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-15-35 · Cited by 2,097
Hein, S., Arnon, E., Kostin, S., Schönburg, M., Elsässer, A., Polyakova, V., Bauer, E. P., Klövekorn, W.-P., & Schaper, J. (2003) · Circulation · doi:10.1161/01.cir.0000051865.66123.b7 · Cited by 1,102
Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice
Baumgartner, H., Hung, J., Bermejo, J., Chambers, J. B., Evangelista, A., Griffin, B. P., Iung, B., Otto, C. M., Pellikka, P. A., & Quinones, M. (2009) · European Journal of Echocardiography · doi:10.1093/ejechocard/jen303 · Cited by 967
Carabello, B. A., & Paulus, W. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60211-7 · Cited by 818
Normal values for cardiovascular magnetic resonance in adults and children
Kawel-Boehm, N., Maceira, A., Valsangiacomo-Buechel, E. R., Vogel-Claussen, J., Turkbey, E. B., Williams, R., Plein, S., Tee, M., Eng, J., & Bluemke, D. A. (2015) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-015-0111-7 · Cited by 746
Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis
Weidemann, F., Herrmann, S., Störk, S., Niemann, M., Frantz, S., Lange, V., Beer, M., Gattenlöhner, S., Voelker, W., Ertl, G., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.847772 · Cited by 706
Dweck, M. R., Boon, N. A., & Newby, D. E. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.093 · Cited by 692
Self-citation
Cited by
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab395 · Cited by 5,685
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Beyersdorf, F., Vahanian, A., Milojevic, M., Praz, F., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2021) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezab389 · Cited by 622
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · EuroIntervention · doi:10.4244/eij-e-21-00009 · Cited by 372
Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis
Bing, R., Cavalcante, J. L., Everett, R. J., Clavel, M.-A., Newby, D. E., & Dweck, M. R. (2019) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2018.11.026 · Cited by 273
Self-citation
Metadata
- Authors
- Musa, T. A., Treibel, T. A., Vassiliou, V. S., Captur, G., Singh, A., Chin, C., Dobson, L. E., Pica, S., Loudon, M., Malley, T., Rigolli, M., Foley, J. R. J., Bijsterveld, P., Law, G. R., Dweck, M. R., Myerson, S. G., McCann, G. P., Prasad, S. K., Moon, J. C., & Greenwood, J. P.
- Venue
- Circulation
- Published
- 2018-10-30
- Volume
- 138
- Issue
- 18
- Pages
- 1935-1947
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2831361703
- Cited by
- 255
- References
- 32
- FWCI
- 19.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myocardial Scar and Mortality in Severe Aortic Stenosis: Data From the BSCMR Valve Consortium. https://app.cochat.ai/papers/10.1161/circulationaha.117.032839
- The paper
- Musa, T. A., Treibel, T. A., Vassiliou, V. S., Captur, G., Singh, A., Chin, C., Dobson, L. E., Pica, S., Loudon, M., Malley, T., Rigolli, M., Foley, J. R. J., Bijsterveld, P., Law, G. R., Dweck, M. R., Myerson, S. G., McCann, G. P., Prasad, S. K., Moon, J. C., & Greenwood, J. P. (2018). Myocardial Scar and Mortality in Severe Aortic Stenosis: Data From the BSCMR Valve Consortium. Circulation. https://doi.org/10.1161/circulationaha.117.032839
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.